Cytosorbents
CTSO
#9850
Rank
A$63.57 M
Marketcap
A$1.01
Share price
-1.36%
Change (1 day)
-32.96%
Change (1 year)

Cytosorbents (CTSO) - Net assets

Net assets on the balance sheet as of September 2025 : A$13.42 Million

According to Cytosorbents's latest financial reports the company has A$13.42 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cytosorbents - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$17.85 M-48.19%
2023-12-31$A$34.46 M-33.7%
2022-12-31$A$51.98 M-39.78%
2021-12-31$A$86.31 M-16.21%
2020-12-31$A$0.10 B2010.24%
2019-12-31$A$4.88 M-79.69%
2018-12-31$A$24.03 M82.86%
2017-12-31$A$13.14 M608.49%
2016-12-31$A$1.85 M-83.54%
2015-12-31$A$11.27 M132.74%
2014-12-31$A$4.84 M-130.28%
2013-12-31$-A$16 Million42.97%
2012-12-31$-A$11.19 Million13.68%
2011-12-31$-A$9.85 Million1962.78%
2010-12-31$-A$0.48 Million-133.8%
2009-12-31$A$1.41 M-57.8%
2008-12-31$A$3.34 M-2903.44%
2007-12-31$-A$0.12 Million-103.98%
2006-12-31$A$2.99 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Meridian Bioscience
VIVO
A$0.54 B 3,980.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$7.51 B 55,863.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
A$35.17 B 261,873.39%๐Ÿ‡บ๐Ÿ‡ธ USA